Targeted Therapeutics Market Top Trends, Global Analysis, Forecast and Opportunities Analysis Report 2028

High demand for precision medicine and increasing healthcare expenditure are significant factors driving global targeted therapeutics market revenue growth

Emergen Research's new report, titled 'Global Targeted Therapeutics Market,' is methodically curated by our team of analysts with readers' comprehension in mind, and includes a comprehensive database of industry distribution. The report examines historical and current market scenarios in order to forecast the global Targeted Therapeutics Market outlook over the forecast period (2021-2028). Researchers took a comprehensive approach to global market analysis, highlighting the factors that influence the market's overall growth. The research employs effective analytical tools such as SWOT analysis and Porter's Five Forces to examine the strengths, weaknesses, opportunities, and threats associated with the growth of various market segments.

The global targeted therapeutics market size is expected to reach USD 162.89 Billion and register a revenue CAGR of 7.1% over the forecast period, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to increasing prevalence of different cancers. Various drugs for chemotherapy are incapable of differentiating between healthy and cancer cells, and thus can kill both kinds of cells. Targeted therapeutics, on the other hand, is a cancer treatment that makes use of drugs to target the exact proteins and genes that support survival and growth of cancer cells. Using targeted therapeutics, doctors influence the tissue environment that aids the spread of cancer or target cells associated with growth of cancer such as blood vessel cells. Also, targeted therapeutics is frequently used in combination with chemotherapy and other treatments. Over the years, various targeted therapies have been sanctioned by the US Food and Drug Administration, owing to growing prevalence of various kinds of cancers.

Claim Your FREE Sample Copy with Table of content @ https://www.emergenresearch.com/request-sample/842

Competitive Landscape:

The latest study provides an insightful analysis of the broad competitive landscape of the global Targeted Therapeutics market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. The report analyzes various elements of the market’s competitive scenario, such as the regulatory standards and policies implemented across the industry over recent years. Our team of experts has leveraged several powerful analytical tools, such as Porter’s Five Forces analysis and SWOT analysis, to deliver a comprehensive overview of the global Targeted Therapeutics market and pinpoint the fundamental growth trends. 

The leading market contenders listed in the report are:

Amgen Inc., Genentech Inc., Arcus Biosciences Inc., Gilead Sciences Inc., AstraZeneca PLC, Serina Therapeutics Inc., F. Hoffman-La Roche Co., Agenus Inc., Pfizer Inc., and Aurinia Pharmaceutical Inc

Global Targeted Therapeutics Market Highlights:

  • Regional demand estimation and forecast
  • Product Mix Matrix
  • RD Analysis
  • Cost-Benefit Analysis
  • Pre-commodity pricing volatility
  • Supply chain optimization analysis
  • Technological updates analysis
  • Raw Material Sourcing Strategy
  • Competitive Analysis
  • Mergers Acquisitions
  • Location Quotients Analysis
  • Carbon Footprint Analysis
  • Patent Analysis
  • Vendor Management

Key Parameters Analyzed in This Section:

  • Company Profiles
  • Gross Revenue
  • Profit margins
  • Product sales trends
  • Product pricing
  • Industry Analysis
  • Sales distribution channels

Regional Segmentation:

  • North America
  • Latin America
  • Europe
  • Middle East Africa
  • Asia Pacific

Key Points Covered in This Section:

  • Regional contribution
  • Estimated revenue generation
  • Vital data and information about the consumption rate in all the leading regional segments
  • An expected rise in market share
  • Forecast growth in the overall consumption rate

To Visit Full Study of Targeted Therapeutics Market Research Report @ https://www.emergenresearch.com/industry-report/targeted-therapeutics-market

Some Key Highlights from the Report

  • In July 2021, Bicycle Therapeutics PLC, which is a biotechnology firm engaged in development of innovative and differentiated therapeutics class on the basis of its proprietary bicyclic peptide technology called Bicycle, made an announcement about entering into a global collaboration and license contract with Ionis Pharmaceuticals for tissue-targeted delivery of oligonucleotide therapeutics deploying Bicycles with high affinity to transferrin receptor (TfR1).
  • Among the therapy segments, monoclonal antibodies segment revenue is expected to account for a significantly robust revenue share over the forecast period. Monoclonal antibodies delivering cytotoxic molecules are capable of precisely killing cancer cells. Antibody, after being bound to its target cell, releases toxic molecule, including a poisonous chemical or radioactive substance that is taken up by the target cell and eventually destroys that cell. These toxins do not affect cells devoid of the antibody target. Examples of monoclonal antibody comprise trastuzumab (certain breast cancers), alemtuzumab (certain chronic leukemias), and cetuximab (certain colorectal, head, lung, and neck cancers).
  • Prostate cancer is the second-most cause of cancer deaths among men in the US. Currently used radiation therapy and prostatectomy are often supplemented with hormonal therapies for prostate cancer treatment. Also, in case of prostate cancer, recurrence is common, and many patients develop metastatic prostate cancer where chemotherapy is moderately effective and required targeted therapeutics after initial therapies.
  • Targeted therapeutics market in North America accounted for largest revenue share in 2020, attributed to rapid adoption of advanced technologies, increasing incidence of cancer, and high healthcare expenditure. In addition, presence of leading market players such as Pfizer Inc. and Amgen Inc. is expected to support market growth in this region.

Market Overview:

The report bifurcates the Targeted Therapeutics market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.

Segments Covered in this report are:

  • Therapy Outlook (Revenue, USD Billion; 2018–2028)
    • Monoclonal Antibodies
    • Small Molecule Inhibitors
  • Disease Indication Outlook (Revenue, USD Billion; 2018–2028)
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Leukemia
    • Lymphoma
    • Multiple Sclerosis
    • Melanoma
    • Others
  • End-use Outlook (Revenue, USD Billion; 2018–2028)
    • Hospitals
    • Cancer Treatment Centers
    • Research Institutes
    • Others

Get An Impressive Discount On This Report @ https://www.emergenresearch.com/request-discount/842

Key reasons to buy the Global Targeted Therapeutics Market report:

  1. The latest report comprehensively studies the global Targeted Therapeutics market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
  2. The report offers an insightful analysis of the regional outlook of the market.
  3. It offers a detailed account of the end-use applications of the products services offered by this industry.
  4. The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.

Request Customization as per your specific requirement @ https://www.emergenresearch.com/purchase-enquiry/842

Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.

Latest Published Reports by Emergen Research:

calcite market:

https://www.emergenresearch.com/industry-report/calcite-market

healthcare supply chain management market:

https://www.emergenresearch.com/industry-report/healthcare-supply-chain-management-market

dewatering equipment market:

https://www.emergenresearch.com/industry-report/dewatering-equipment-market

industrial lubricants market:

https://www.emergenresearch.com/industry-report/industrial-lubricants-market

cast elastomers market:

https://www.emergenresearch.com/industry-report/cast-elastomers-market

healthcare it integration market:

https://www.emergenresearch.com/industry-report/healthcare-it-integration-market

risk-based monitoring software market:

https://www.emergenresearch.com/industry-report/risk-based-monitoring-software-market

next generation implants market:

https://www.emergenresearch.com/industry-report/next-generation-implants-market

next-generation display materials market:

https://www.emergenresearch.com/industry-report/next-generation-display-materials-market

cognitive assessment and training market:

https://www.emergenresearch.com/industry-report/cognitive-assessment-and-training-market


Ravi Thakre

27 Blog Beiträge

Kommentare